Atlas Arteria Limited (MAQAF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Atlas Arteria Limited (MAQAF) trades at $3.60 with AI Score 46/100 (Grade C). Atlas Arteria Limited owns, develops, and operates toll roads, primarily holding a 13. 4% interest in the Dulles Greenway toll road in Virginia. Market cap: $5.22B, Sector: Industrials.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for MAQAF: MAQAF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MAQAF against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MAQAF: the 1 perspectives are evenly split.
How is this calculated? →Atlas Arteria Limited (MAQAF) Industrial Operations Profile
Atlas Arteria Limited, an Australian infrastructure company, focuses on owning and operating toll roads, including a significant stake in the Dulles Greenway. With a high dividend yield and moderate beta, the company provides investors exposure to stable, long-term infrastructure assets within the industrials sector.
What Is the Investment Thesis for MAQAF?
Atlas Arteria Limited presents a compelling, albeit risky, investment case due to its focus on toll road infrastructure. The company's high dividend yield of 8.68% may attract income-seeking investors. However, the P/E ratio of 32.48 suggests a premium valuation. Growth catalysts include potential increases in traffic volume on the Dulles Greenway and strategic acquisitions of additional toll road assets. The company's low beta of 0.43 indicates lower volatility compared to the broader market. Key risks include regulatory changes impacting toll rates and economic downturns reducing traffic volume. Investors should closely monitor traffic data, regulatory developments, and macroeconomic indicators to assess the company's long-term prospects.
Based on FMP financials and quantitative analysis
MAQAF Key Highlights
- Market capitalization of $5.22B reflects the company's significant presence in the toll road infrastructure sector.
- Profit margin of 169.8% indicates strong profitability, potentially driven by efficient operations and favorable tolling agreements.
- Gross margin of 23.8% reflects the difference between toll revenue and the costs associated with operating and maintaining the toll road infrastructure.
- Dividend yield of 8.68% offers an attractive income stream for investors, supported by the company's stable cash flows from toll collections.
- Beta of 0.43 suggests lower volatility compared to the overall market, making it a potentially defensive investment during economic downturns.
Who Are MAQAF's Competitors?
MAQAF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BCHHF Bucher Industries AG | $395.00 | +0.00% | $3.88B | 48 |
| FGWLF Flughafen Wien AG | $56.24 | +0.00% | $4.72B | 53 |
| GAERF Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. | $14.65 | +0.00% | $4.93B | 52 |
| HSHZY Hoshizaki Corporation | $8.36 | +0.00% | $4.69B | 46 |
| JEXYF Jiangsu Expressway Company Limited | $1.40 | +0.00% | $7.05B | 56 |
| JEXYY Jiangsu Expressway Company Limited | $23.40 | +1.74% | $5.89B | 62 |
| SCGEY Shoucheng Holdings Limited | $8.33 | +0.00% | $1.89B | 56 |
| ACA Arcosa, Inc. | $144.88 | -0.06% | $7.11B | 53 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MAQAF's Key Strengths?
- Stable revenue stream from toll collections.
- High profit margin and attractive dividend yield.
- Low beta indicates lower volatility compared to the market.
- Strategic asset in the Dulles Greenway toll road.
What Are MAQAF's Weaknesses?
- Concentration of assets in a limited number of toll roads.
- Dependence on traffic volume and toll rates.
- Exposure to regulatory and political risks.
- High P/E ratio suggests a premium valuation.
What Could Drive MAQAF Stock Higher?
- Potential acquisitions of additional toll road assets to expand the company's portfolio.
- Traffic volume growth on the Dulles Greenway due to population growth and economic development.
- Implementation of toll rate adjustments to offset inflation and maintain revenue.
- Operational efficiency improvements to reduce operating costs and increase profitability.
- Strategic partnerships to enhance capabilities and expand market reach.
What Are the Key Risks for MAQAF?
- Economic downturns reducing traffic volume and toll revenue.
- Regulatory changes impacting toll rates and operating conditions.
- Increased competition from alternative transportation modes.
- Infrastructure damage from natural disasters.
- Limited liquidity due to OTC market trading.
What Are the Growth Opportunities for MAQAF?
- Expansion of Toll Road Network: Atlas Arteria can pursue growth through strategic acquisitions of existing toll roads or the development of new toll road projects. The global toll road market is estimated to reach $70 billion by 2030, presenting significant opportunities for expansion. Successful acquisitions would increase revenue and diversify the company's geographic footprint. Timeline: Ongoing.
- Traffic Volume Growth on Dulles Greenway: Increasing traffic volume on the Dulles Greenway, driven by population growth and economic development in the Washington D.C. metropolitan area, would directly boost toll revenue. Investments in infrastructure improvements and marketing initiatives can further stimulate traffic growth. The Dulles Greenway serves a rapidly growing region, offering potential for sustained traffic increases. Timeline: Ongoing.
- Toll Rate Adjustments: Atlas Arteria can increase revenue by implementing periodic toll rate adjustments, subject to regulatory approvals and market conditions. Toll rate increases can offset inflation and maintain the real value of toll revenue. The company's ability to negotiate favorable tolling agreements with regulatory authorities is crucial for maximizing revenue. Timeline: Ongoing.
- Operational Efficiency Improvements: Implementing operational efficiency improvements, such as advanced tolling technologies and streamlined maintenance procedures, can reduce operating costs and increase profitability. Investing in technology and process optimization can enhance the company's competitiveness and improve its financial performance. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with other infrastructure companies, construction firms, or technology providers can enhance Atlas Arteria's capabilities and expand its market reach. Collaborations can facilitate access to new markets, technologies, and expertise. Strategic alliances can create synergies and accelerate growth. Timeline: Ongoing.
What Opportunities Does MAQAF Have?
- Acquisition of additional toll road assets.
- Expansion of traffic volume on existing toll roads.
- Implementation of toll rate adjustments.
- Operational efficiency improvements.
What Threats Does MAQAF Face?
- Economic downturns reducing traffic volume.
- Regulatory changes impacting toll rates.
- Increased competition from alternative transportation modes.
- Infrastructure damage from natural disasters.
What Are MAQAF's Competitive Advantages?
- Concession agreements with governments provide exclusive rights to operate toll roads for a specified period.
- High barriers to entry due to the significant capital investment and regulatory approvals required to build and operate toll roads.
- Strategic location of toll roads in high-traffic corridors provides a competitive advantage.
- Established relationships with regulatory authorities and government agencies.
What Does MAQAF Do?
Atlas Arteria Limited, formerly known as Macquarie Atlas Roads Limited, was established in 2009 and is headquartered in Melbourne, Australia. The company specializes in the ownership, development, and operation of toll roads across various geographies. Its primary asset is a 13.4% stake in toll road investors partnership II (TRIP II), the concessionaire for the Dulles Greenway, a 22-kilometer toll road located in Virginia, USA. This toll road serves as a critical transportation artery, connecting Washington Dulles International Airport with communities in Loudoun and Fairfax counties. Atlas Arteria generates revenue through the collection of tolls from vehicles using its road networks. The company rebranded to Atlas Arteria Limited in May 2018, reflecting its strategic focus on infrastructure assets. The company aims to provide long-term value to its shareholders through active asset management and strategic investments in toll road infrastructure.
What Products and Services Does MAQAF Offer?
- Owns and operates toll road infrastructure assets.
- Collects toll revenue from vehicles using its road networks.
- Manages and maintains toll road facilities.
- Invests in infrastructure improvements and expansion projects.
- Negotiates tolling agreements with regulatory authorities.
- Monitors traffic volume and revenue trends.
- Manages financial performance and shareholder returns.
How Does MAQAF Make Money?
- Generates revenue primarily through toll collections from vehicles using its toll roads.
- Revenue is dependent on traffic volume, toll rates, and the length of the toll road.
- Manages operating expenses related to road maintenance, toll collection, and administrative costs.
- Invests in capital improvements to maintain and expand its toll road infrastructure.
What Industry Does MAQAF Operate In?
Atlas Arteria Limited operates within the industrial infrastructure sector, which is characterized by long-term assets, stable cash flows, and significant capital investments. The toll road industry is influenced by factors such as traffic volume, toll rates, regulatory policies, and economic conditions. Competitors include other toll road operators and infrastructure investment firms. The industry is experiencing growth driven by increasing urbanization, rising vehicle ownership, and government initiatives to improve transportation infrastructure. Atlas Arteria's focus on developed markets and strategic asset management positions it to capitalize on these trends.
Who Are MAQAF's Key Customers?
- Commuters and local residents who use the Dulles Greenway for daily travel.
- Businesses and commercial vehicles that rely on the toll road for transportation of goods and services.
- Tourists and visitors traveling to and from Washington Dulles International Airport.
- Trucking companies transporting goods along the toll road corridor.
Atlas Arteria Limited (MAQAF) Valuation Context
Valued at $5.22B, MAQAF is classified as a mid-cap stock. Relative to its peer group, MAQAF's quantitative score of 46/100 is roughly in line with the peer average of 51/100.
ROE 3%Key Financial Metrics
Return on equity for Atlas Arteria Limited stands at 3.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.7%, showing how much profit it generates from its asset base. MAQAF trades at a trailing price-to-earnings ratio of 35.94, above the Industrials sector average of ~30x. Its free cash flow yield is 4.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.17 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.8%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
Atlas Arteria Limited's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.33 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project Atlas Arteria Limited revenue of about $132.6M for fiscal 2026, with EPS near $0.20. The estimate reflects 5 contributing analysts.
MAQAF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Stable revenue stream from toll collections.
- High profit margin and attractive dividend yield.
- Low beta indicates lower volatility compared to the market.
- Strategic asset in the Dulles Greenway toll road.
Bear Case
- Concentration of assets in a limited number of toll roads.
- Dependence on traffic volume and toll rates.
- Exposure to regulatory and political risks.
- High P/E ratio suggests a premium valuation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
MAQAF Latest News
No recent news available for MAQAF.
MAQAF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MAQAF.
Price Targets
Wall Street price target analysis for MAQAF.
MAQAF MoonshotScore
What does this score mean?
The MoonshotScore rates MAQAF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Hugh Wehby DipInvRel
Unknown
Hugh Wehby's background and career history are not fully detailed in the provided data. However, his designation of DipInvRel suggests expertise in investor relations and financial communications. Further research would be needed to determine his specific experience and qualifications in the infrastructure sector.
Track Record: Due to limited information, Hugh Wehby's specific achievements and strategic decisions as CEO are unknown. Further research is needed to assess his track record and contributions to Atlas Arteria Limited.
MAQAF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Atlas Arteria Limited (MAQAF) may have limited regulatory oversight and reporting requirements compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies in this tier often have minimal financial disclosure and may not meet the listing standards of higher-tier exchanges. This can result in increased risks for investors due to the lack of transparency and potential for fraudulent activities. Investing in OTC Other stocks requires a higher degree of due diligence and risk assessment.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in MAQAF.
- Lower liquidity can lead to price volatility and difficulty in executing trades.
- Potential for fraudulent activities due to less regulatory oversight.
- Higher risk of delisting or trading suspension compared to exchange-listed stocks.
- Information asymmetry can disadvantage investors.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- The company has been operating since 2009.
- Atlas Arteria Limited owns tangible assets in the form of toll road infrastructure.
- The company generates revenue from toll collections.
MAQAF Industrials Stock FAQ
What does Atlas Arteria Limited do?
Atlas Arteria Limited is an infrastructure company that owns, develops, and operates toll roads. Its primary asset is a 13.4% interest in the Dulles Greenway toll road in Virginia, USA. The company generates revenue by collecting tolls from vehicles using its road networks. Atlas Arteria focuses on managing and enhancing its existing assets while seeking opportunities to expand its portfolio through strategic acquisitions. The company aims to provide long-term value to its shareholders through stable cash flows and sustainable growth.
What are the main risks for MAQAF?
Atlas Arteria faces several risks inherent to the toll road industry. Economic downturns can reduce traffic volume, impacting toll revenue. Regulatory changes, such as limits on toll rate increases, can also negatively affect profitability. Competition from alternative transportation modes, such as public transportation or ride-sharing services, poses a threat. Additionally, infrastructure damage from natural disasters or accidents can disrupt operations and require costly repairs. The company's OTC listing also introduces liquidity risks.
What are the key factors to evaluate for MAQAF?
Atlas Arteria Limited (MAQAF) holds an AI score of 46/100 (low). Not financial advice.
How frequently does MAQAF data refresh on this page?
MAQAF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MAQAF's recent stock price performance?
Atlas Arteria Limited (MAQAF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Stable revenue stream from toll collections. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MAQAF overvalued or undervalued right now?
Valuing Atlas Arteria Limited (MAQAF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MAQAF?
Before investing in Atlas Arteria Limited (MAQAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding MAQAF to a portfolio?
Key strength of Atlas Arteria Limited (MAQAF): Stable revenue stream from toll collections. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis is pending, limiting the depth of some sections.